Industry Reports

India bets ₹10,000 crore on a leap from generic drugs to biologics

Friday, July 17, 2026 - 22:43
0 0
India bets ₹10,000 crore on a leap from generic drugs to biologics
Biopharma SHAKTI aims to build the research, clinical-trial and manufacturing ecosystem India needs to move from low-cost generic copies to high-value biological medicines.

Read More
Previous Article

HSBC dangles 19x leverage to lure NRIs under RBI’s dollar deposit scheme

Next Article

Hindi cinema has no fresh stars. Can it still charm Gen Z audiences to theatres?

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Related Posts

Foreign insurers raise India bets as reforms reshape insurance sector

Foreign insurers raise India bets as reforms reshape...

Friday, July 17, 2026
0
0
Hindi cinema has no fresh stars. Can it still charm Gen Z audiences to theatres?

Hindi cinema has no fresh stars. Can it still charm ...

Friday, July 17, 2026
0
0
Aera's plan to link airport fees to project completion meets industry resistance

Aera's plan to link airport fees to project completi...

Friday, July 17, 2026
0
0
Centre approves Gujarat shipbuilding cluster, Vadinar repair hub

Centre approves Gujarat shipbuilding cluster, Vadina...

Friday, July 17, 2026
0
0
Govt tightens arbitration fee rules as NHAI hits the road to zero debt

Govt tightens arbitration fee rules as NHAI hits the...

Friday, July 17, 2026
0
0
India will offer 9% deployment incentive for startups to hasten chip designs: ISM CEO

India will offer 9% deployment incentive for startup...

Friday, July 17, 2026
0
0

Comments (0)

User